March 2013Successful acquisition of U.S. company Complete GenomicsIntense industry competition made us even more determined to acquire the listed company Complete Genomics. We have been able to reduce costs right from the inception stage by utilizing CG's cutting-edge biotechnologies and instrument technologies.
July 2014The BGISEQ-1000 sequencing systemThe system was approved by the State Food and Drug Administration in 2014, and this development generated much market buzz for related stocks.
June 2015The Revolocity sequencing systemThe Revolocity is a fully-integrated "super sequencer", with its first users being Mater, a health services provider in Australia, and the Nijmegen University Medical Center in the Netherlands.
Oct 2015The BGISEQ-500 high-throughput desktop sequencing systemMGI Tech has complete ownership of intellectual property rights to the device. It can satisfy all clinical needs, and at full speed, can complete the entire sequencing process within 24 hours. BGISEQ-500 has received CFDA and CE approval successively. Supports the development of precise medicine and brings the benefits of gene technology to the people.
Nov 2016The BGISEQ-50 high-throughput desktop sequencing systemBroad array of applications with no constraints in terms of space. Suitable for use at low-pressure, high-altitude environments. Multiple integrated functions are enclosed within its compact and simple structure, and its small footprint makes for easy placement.
Apr 2017Mobile medical vehicleThe mobile workstation allows for on-site screening for echinococcosis in remote areas, thus providing residents in these areas with improved and convenient testing services.
Jul 2017ISO 13485MGI receied ISO 13485 approval.
Sep 2017Circulating tumor cell separator (CTC)Technology and intelligence come together perfectly in this epoch-making clinical trial that enhances the separation and enrichment efficiency by as much as 100,000 times, with a user-oriented, fully-automated, real-time smart cell-seeking technology. The tumor has nowhere to hide!
Oct 2017MGISEQ-2000 MGISEQ-200 MGIFLP MGIUS-R3Two new sequencers for more power and lower cost, as well as a highly integrated modular NGS workstation and a remote robotic ultrasound system for exploring more possibility of the future.
The future is here, with our all-encompassing platformWe have already kickstarted research and development in many areas, including sequencing, mass spectrometry, and imaging. These R&D efforts will provide full support to various industries and benefit all of society while establishing new benchmarks for emerging Chinese industries.
Fully-automated data plantProvides real-time overview. Complete bioinformatics equipment sets with full lifecycle allow us to set up platforms and providesolutions and technical assurance for nationwide initiatives like Big Health.
BGI was founded in 1999 with the vision of trans-omics for a better life and has since become the largest genomic organization in the world. With the research and business presences based on genetic research achievements and biotech application
in human health, BGI provides the integrated genomics-based services and solutions across a broad range of applications including scientific research, healthcare provision, agriculture and bio-sustainability complying with bioethical principles.
MGI Tech Co., Ltd., is a subsidiary of the BGI, which helps BGI to produce biolo gical
equipment that provides real-time information overview and comes with full life- cycle
coverage, such as genetic sequencer, mass spectrometer, medical image platform and
a number of comprehensive solutions. MGI will support BGI with these tools and sol-
utions to promote development of BGI in precision medicine, agriculture and many other
areas. So far, MGI Tech has owned more than 100 of patents and 500 staffs..